Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Semin Immunol. 2008 Jun 9;20(5):267–275. doi: 10.1016/j.smim.2008.04.001

Figure 1.

Figure 1

Schematic diagram of the EGFR wild type protein showing the area of in-frame deletion which forms EGFRvIII. During the deletion amino acids 6 and 273 are split forming a novel glycine at the junction of amino acids 5 and 274. PEPvIII is a 13 amino acid peptide with a terminal cysteine added to facilitate conjugation to KLH.

HHS Vulnerability Disclosure